ArticleCureus2025
Risk Factors and Clinical Features of Herpes Zoster in Children: A Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical Characteristics and Determinants of Complications in Pediatric Herpes Zoster Requiring Hospitalization.Children (Basel, Switzerland) · 2026Article
- Contemporaneous varicella and zoster or disseminated zoster? A diagnostic challenge in an HIV-positive child.Southern African journal of infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpes zoster (HZ) is an infectious disease resulting from the reactivation of the varicella-zoster virus (VZV), which remains latent in ganglionic neurons after primary varicella infection. The occurrence of HZ in the pediatric population is relatively uncommon, and identifying risk factors that facilitate VZV reactivation is important. This study presents three cases of children with distinct clinical manifestations of HZ, considering various predisposing factors for disease development. The described patients included a three-year-old boy with a typical form of HZ during maintenance therapy for acute lymphoblastic leukemia (ALL). The second case was a 16-year-old girl with disseminated HZ and a diagnosis of acute myeloid leukemia (AML) who had multiple treatment-related complications. The third patient was an immunocompetent 15-year-old boy with Ramsay Hunt syndrome (RHS). Variables analyzed included immune status, the presence of comorbidities, administered medications, and a history of varicella infection. Based on available literature and case analysis, selected risk factors were discussed, including early childhood varicella infection, acquired immunodeficiencies, and conditions requiring immunosuppressive therapy. This study emphasizes the importance of early identification of at-risk children. Such an approach may facilitate the consideration of preventive strategies and, in the case of symptomatic infection, lead to earlier diagnosis and more effective treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.